Abstract
Aim: To analyse the association between polymorphisms of CYP genes and the risk for head and neck cancer susceptibility. Materials and Methods: A case-control study using molecular epidemiological method was conducted. Various polymorphism of CYP1A1 gene from DNA samples of 105 cases and 110 controls were detected by PCR method. Results: All sites of CYP1A1 in HNC cases showed no significant results in relation to the three genotypes i.e., Ile/Ile, Ile/Val and Val/Val. Larynx is significant in relation to CYP2E1 I/I genotype whereas oral cavity and pharynx showed no significant results. In CYP1A1, except for Ile/Val, the other two Ile/Ile and Val/Val showed no significant results and in CYP2E1 all the genotypes i.e., I/I, I/I and i/I shows significant results. Together, all the three genotypes of CYP1A1(Ile/Ile, Ile/Val and Val/Val) were statistically significant whereas in CYP2E1 except I/I, the remaining two genotypes (I/I and i/i) were statistically significant. When combination of both the genes are considered, Ile/Val in CYP1A1 and I/i and i/I in CYP2E1 show high significance. Conclusion: CYP1A1 Ile/Val and CYP2E1 I/i and i/i genotypes showed genetic susceptibility biomarkers for head and neck cancers. Risk increases when the metabolic enzymes as products of these genes seem to interact with tobacco carcinogens, the mechanism of which is still not understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5:127–135
Ferlay J, Bray F, Pisani P, Parkin DM (2004) Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. IARC Press, Lyon, France
National Cancer Registry Programme (1992) Biennial report (1988–1989) of the national cancer registry programme. Indian Council of Medical Research, New Delhi
Parkin DM, Whelan SL, Ferlay J, Raymond LA, Woung J (1997) Cancer Incidence in five continents, vol VII, no 143. IARC Scientific Publications, Lyon
Sanderson RJ, Ironside JA (2002) Squamous cell carcinomas of the head and neck. BMJ 325:822–827
Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391–407
Anttila S, Vainio H, Hietanen E, Camus AM, Malaveille C, Brun G (1992) Immunohistochemical detection of pulmonary cytochrome P-4501A and metabolic activities associated with P4501A1 and P4501A2 isozymes in lung cancer patients. Environ Health Perspect 98:179–182
Hayes JD, Pulford DJ, Hayes JD, Pulford DJ (1995) The glutathione- S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445–600
Townsend DM, Tew KD (2003) Can cer drugs, genetic variation and the glutathione- S-transferase gene family. Am J Pharm Ecogenomics 3:157–172
Park JY, Muscat JE, Ren Q et al (1997) CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomark Prev 6:791–797
Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-fl anking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem (Tokyo) 110:559–565
Miller SA1, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Murata M, Watanabe M, Yamanaka M et al (2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST)M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165:171–177
Le Marchand L, Donlon T, Seifried A, Wilkens LR (2002) Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomark Prev 11:1019–1024
Wu X, Zhao H, Suk R, Christiani DC (2004) Genetic susceptibility to tobacco-related cancer. Oncogene 23:6500–6523
McWilliams JE (2000) Genetic polymorphisms in head and neck cancer risk. Head Neck 22(6):609–617
Masood N, Malik FA, Jabeen IM, Baig RM, Kayani MA (2011) A novel CYP1A1 gene polymorphism and the risk of head and neck cancer in Pakistani population. Afr J Biotechnol 10(27):5273–5280
Shanmugaratnam K (1982) Nasopharynx. In: Schottenfeld D, Fraumeni Jr. JF (eds) Cancer epidemiology and prevention. Saunders Company, Philadelphia, WB, pp 536–553
Llewellyn CD, Johnson NW, Warnakulasuriya KA (2004) Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 33:525–532
Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H (1998) Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 20(3):216–223
Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Sem Cancer Biol 12:421–429
Toefil L, Oana CT, Horea AA, Ovidiu M (2007) Head and neck cancer, epidemiology and histological aspects-Part 1: a decade’s results 1993–2002. J Cranio Maxill Surg 35(2):120–125
Olshan AF, Weissler MC, Watson MA, Bell DA (2000) GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomark Prev 9:185–191
Pöschl G, Seitz HK (2004) Alcohol and cancer. Alcohol Alcohol 39:155–165
Caro AA, Cederbaum AI (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27–42
Li Z, Tan W, Shao K (2000) Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1. Chin J Oncol 22:5–7
Cheng YJ et al (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 89:1207–1212
Mittal RD, Srivastava DS (2005) A M, B M: Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in north India. Asian Pac J Cancer Prev 6:6–9
Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266:1–9
Kim JW, Lee CG, Park YG et al (2000) Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 88:2082–2091
Sikdar N, Mahmud SA, Paul RR, Roy B (2003) Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 195:33–42
Soya SS, Vinod T, Reddy KS, Gopalakrishnan S, Adithan C (2008) CYP2E1 polymorphisms and gene–environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics 9(5):551–560
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 The Author(s)
About this chapter
Cite this chapter
Anuradha, A., Lakshmi Kalpana, V., Kirmani, N., Rao, P.J. (2016). CYP Polymorphism and Its Association with Tobacco Usage and Susceptibility to Head and Neck Cancer. In: Avadhanam, S., Jyothsna, G., Kashyap, A. (eds) Next Generation DNA Led Technologies. SpringerBriefs in Applied Sciences and Technology(). Springer, Singapore. https://doi.org/10.1007/978-981-287-670-6_5
Download citation
DOI: https://doi.org/10.1007/978-981-287-670-6_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-287-669-0
Online ISBN: 978-981-287-670-6
eBook Packages: EngineeringEngineering (R0)